As of April 16, 2025, Dyne Therapeutics (DYN) has a market cap of $0.89 billion USD. According to our data, Dyne Therapeutics is ranked No.5202 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.89 B |
-62.96%
|
Dec 31, 2024 | $2.40 B |
77.14%
|
Dec 29, 2023 | $1.35 B |
14.75%
|
Dec 30, 2022 | $1.18 B |
-2.52%
|
Dec 31, 2021 | $1.21 B |
-43.38%
|
Dec 31, 2020 | $2.14 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
![]() USA
|
![]() Wave Life Sciences
WVE
|
$0.96 B |
-0.000 M
|
![]() Singapore
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
![]() USA
|
![]() PTC Therapeutics
PTCT
|
$3.70 B |
-0.000 M
|
![]() USA
|
![]() Ultragenyx
RARE
|
$3.32 B |
0.000 M
|
![]() USA
|
![]() Avidity Biosciences
RNA
|
$3.21 B |
0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.33 B |
-0.000 M
|
![]() USA
|
![]() Solid Biosciences
SLDB
|
$0.21 B |
0.000 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() Rocket Pharmaceuticals
RCKT
|
$0.70 B |
0.000 M
|
![]() USA
|
Market Cap | = | DYN Stock Price | * | DYN Shares Outstanding |
= | $7.85 | * | 0.11 B | |
= | $0.89 B |